Clinical trial
Comparison of 30% Metformin and 2% Nicotinamide Lotion With Kligman Formula in the Treatment of Melasma
Name
PakEmiratesMH2
Description
Comparison of 30% Metformin and 2% Nicotinamide lotion with kligman formula in the treatment of Melasma
Trial arms
Trial start
2022-02-01
Estimated PCD
2023-02-15
Trial end
2023-02-15
Status
Completed
Phase
Early phase I
Treatment
Metformin and Nicotinamide vs Kligman Formula
Comparison of 30% Metformin and 2% Nicotinamide lotion with kligman formula in the treatment of Melasma
Arms:
Kligman formula, Metformin 30% and 2% Nicotinamispde
Size
88
Primary endpoint
Comparison of 30% Metformin and 2% Nicotinamide lotion with kligman formula in the treatment of Melasma
12 weeks
Eligibility criteria
Inclusion Criteria:
* Age between 18-50
* No systemic therapy
* All Co-morbids
Exclusion Criteria:
* Pregnancy
* Age \>50
* Taking oral treatment for melasma
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 88, 'type': 'ACTUAL'}}
Updated at
2023-05-23
1 organization
1 product
1 indication
Organization
Ishtiaq AhmedIndication
Melasma